Search - tctmd.com

Displaying 121 - 140 of 162

Sort: Relevancy | Date

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Daily News

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

June 25, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

RE-VERSE AD：中期分析表明达比加群中和剂似乎安全有效

June 25, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Daily News

真实案例研究凸显新抗凝血剂的胃肠道出血风险

L.A. McKeown

May 04, 2015

News Daily News

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

L.A. McKeown

May 04, 2015

News Daily News

Estudios del Mundo Exponen que Preocupan las Hemorragias Gastrointestinales secundarias a los Nuevos Anticoagulantes

L.A. McKeown

May 04, 2015

News Daily News

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

药剂师有助于大幅改善达比加群酯依从性

Todd Neale

April 17, 2015

News Daily News

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Todd Neale

April 17, 2015

News Daily News

Los Farmacéuticos Podrían Ayudar a Mejorar la Enorme Variación de la Adherencia al Dabigatran

Todd Neale

April 17, 2015

News Daily News

Study Suggests Routine Bridging Harmful for A-fib Patients Interrupting Anticoagulation

December 22, 2014

News Industry News

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

November 09, 2014

News Daily News

达比加群带来的大出血风险更高，颅内出血风险更低

Todd Neale

November 06, 2014

News Daily News

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Todd Neale

November 06, 2014

News Daily News

Dabigatran acarrea un Mayor Riesgo de Hemorragias Graves y un Menor Riesgo de Hemorragias Intracraneales

Todd Neale

November 06, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

Advertisement

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

RE-VERSE AD：中期分析表明达比加群中和剂似乎安全有效

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

真实案例研究凸显新抗凝血剂的胃肠道出血风险

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

Estudios del Mundo Exponen que Preocupan las Hemorragias Gastrointestinales secundarias a los Nuevos Anticoagulantes

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

药剂师有助于大幅改善达比加群酯依从性

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Los Farmacéuticos Podrían Ayudar a Mejorar la Enorme Variación de la Adherencia al Dabigatran

Study Suggests Routine Bridging Harmful for A-fib Patients Interrupting Anticoagulation

Boehringer Ingelheim Initiates U.S. Sites in First-Ever Global Phase III Trial of Investigational Antidote in Patients Taking PRADAXA®

达比加群带来的大出血风险更高，颅内出血风险更低

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Dabigatran acarrea un Mayor Riesgo de Hemorragias Graves y un Menor Riesgo de Hemorragias Intracraneales

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content